News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,867 Results
Type
Article (43554)
Company Profile (322)
Press Release (693981)
Multimedia
Podcasts (111)
Webinars (19)
Section
Business (210879)
Career Advice (2104)
Deals (36727)
Drug Delivery (118)
Drug Development (83344)
Employer Resources (177)
FDA (16782)
Job Trends (15484)
News (357110)
Policy (34101)
Tag
Academia (2602)
Accelerated approval (23)
Adcomms (25)
Allergies (129)
Alliances (51583)
ALS (161)
Alzheimer's disease (1644)
Antibody-drug conjugate (ADC) (278)
Approvals (16965)
Artificial intelligence (477)
Autoimmune disease (117)
Automation (33)
Bankruptcy (372)
Best Places to Work (11772)
BIOSECURE Act (21)
Biosimilars (179)
Biotechnology (190)
Bladder cancer (147)
Brain cancer (56)
Breast cancer (596)
Cancer (4464)
Cardiovascular disease (375)
Career advice (1780)
Career pathing (35)
CAR-T (265)
CDC (47)
Celiac Disease (1)
Cell therapy (695)
Cervical cancer (34)
Clinical research (70599)
Collaboration (1515)
Company closure (4)
Compensation (1048)
Complete response letters (54)
COVID-19 (2768)
CRISPR (87)
C-suite (710)
Cystic fibrosis (141)
Data (5733)
Decentralized trials (2)
Denatured (36)
Depression (115)
Diabetes (462)
Diagnostics (6688)
Digital health (38)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (223)
Drug pricing (184)
Drug shortages (31)
Duchenne muscular dystrophy (214)
Earnings (91455)
Editorial (53)
Employer branding (22)
Employer resources (155)
Events (119517)
Executive appointments (962)
FDA (19556)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1338)
Gene editing (187)
Generative AI (40)
Gene therapy (557)
GLP-1 (959)
Government (4765)
Grass and pollen (7)
Guidances (377)
Healthcare (19043)
HIV (48)
Huntington's disease (40)
IgA nephropathy (77)
Immunology and inflammation (240)
Immuno-oncology (37)
Indications (77)
Infectious disease (3010)
Inflammatory bowel disease (183)
Inflation Reduction Act (13)
Influenza (101)
Intellectual property (214)
Interviews (327)
IPO (16899)
IRA (55)
Job creations (4067)
Job search strategy (1498)
Kidney cancer (15)
Labor market (79)
Layoffs (570)
Leadership (30)
Legal (8414)
Liver cancer (89)
Longevity (13)
Lung cancer (612)
Lymphoma (352)
Machine learning (38)
Management (60)
Manufacturing (696)
MASH (157)
Medical device (13773)
Medtech (13810)
Mergers & acquisitions (20790)
Metabolic disorders (1174)
Multiple sclerosis (143)
NASH (17)
Neurodegenerative disease (282)
Neuropsychiatric disorders (72)
Neuroscience (2749)
NextGen: Class of 2025 (6645)
Non-profit (4551)
Now hiring (60)
Obesity (549)
Opinion (273)
Ovarian cancer (150)
Pain (190)
Pancreatic cancer (192)
Parkinson's disease (253)
Partnered (31)
Patents (452)
Patient recruitment (398)
Peanut (57)
People (60546)
Pharmaceutical (91)
Pharmacy benefit managers (28)
Phase I (21906)
Phase II (31046)
Phase III (23277)
Pipeline (3844)
Policy (276)
Postmarket research (2655)
Preclinical (9349)
Press Release (68)
Prostate cancer (215)
Psychedelics (45)
Radiopharmaceuticals (270)
Rare diseases (741)
Real estate (6299)
Recruiting (71)
Regulatory (24830)
Reports (51)
Research institute (2421)
Resumes & cover letters (360)
Rett syndrome (23)
RNA editing (13)
RSV (73)
Schizophrenia (142)
Series A (222)
Series B (168)
Service/supplier (12)
Sickle cell disease (94)
Special edition (23)
Spinal muscular atrophy (156)
Sponsored (41)
Startups (3758)
State (2)
Stomach cancer (17)
Supply chain (99)
Tariffs (92)
The Weekly (73)
Vaccines (974)
Venture capital (75)
Weight loss (363)
Women's health (74)
Worklife (17)
Date
Today (148)
Last 7 days (563)
Last 30 days (2446)
Last 365 days (30794)
2025 (30191)
2024 (35773)
2023 (40630)
2022 (51799)
2021 (56329)
2020 (54792)
2019 (47401)
2018 (35772)
2017 (33137)
2016 (32662)
2015 (38616)
2014 (32517)
2013 (27630)
2012 (29731)
2011 (30487)
2010 (28497)
Location
Africa (798)
Alabama (77)
Alaska (7)
Arizona (296)
Arkansas (14)
Asia (41869)
Australia (6701)
California (10455)
Canada (3109)
China (1009)
Colorado (437)
Connecticut (447)
Delaware (310)
Europe (89740)
Florida (1548)
Georgia (330)
Hawaii (2)
Idaho (61)
Illinois (797)
India (57)
Indiana (501)
Iowa (20)
Japan (374)
Kansas (122)
Kentucky (36)
Louisiana (24)
Maine (70)
Maryland (1316)
Massachusetts (7581)
Michigan (304)
Minnesota (589)
Mississippi (5)
Missouri (120)
Montana (30)
Nebraska (26)
Nevada (113)
New Hampshire (73)
New Jersey (2823)
New Mexico (29)
New York (2789)
North Carolina (1381)
North Dakota (8)
Northern California (5008)
Ohio (307)
Oklahoma (21)
Oregon (43)
Pennsylvania (2147)
Puerto Rico (19)
Rhode Island (45)
South America (1167)
South Carolina (59)
South Dakota (1)
Southern California (4050)
Tennessee (163)
Texas (1615)
United States (37475)
Utah (310)
Vermont (1)
Virginia (253)
Washington D.C. (78)
Washington State (862)
West Virginia (4)
Wisconsin (95)
Wyoming (2)
737,867 Results for "cadence pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Merck’s WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Phase 2 CADENCE Study in Adults With Combined Post- and Precapillary Pulmonary Hypertension (CpcPH) due to Heart Failure With Preserved Ejection Fraction (HFpEF)
November 19, 2025
·
9 min read
Bio NC
Cadence Expands Pfizer’s License to Molecular Design Software
Cadence Molecular Sciences announced that Pfizer Inc. has signed an agreement to extend and expand access to Cadence® products and programming toolkits for advanced molecular design.
October 25, 2023
·
2 min read
Press Releases
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2025 Results and Provides Business Update
November 13, 2025
·
11 min read
Press Releases
RespireRx Pharmaceuticals Inc. Announces Commencement of Rule 506(c) Private Placement
November 19, 2025
·
16 min read
Press Releases
Driven by a common vision, Mochida Pharmaceutical Co., Ltd. and Duchesnay Inc. sign a partnership to help address the issue of drug gap in Japan
December 15, 2025
·
3 min read
Press Releases
Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August
June 17, 2025
·
1 min read
Press Releases
RespireRx Pharmaceuticals Inc. Announces NIH/NINDS Grant Award and Amended and Restated Patent License Agreement
November 20, 2025
·
20 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 18, 2025
·
12 min read
Press Releases
NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards
October 20, 2025
·
2 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025
November 13, 2025
·
3 min read
1 of 73,787
Next
